Jennifer Denne, MD
Surgery · Bryn Mawr, PANPI 1447318126
Payments from drug & device makers
Across 98 payments — averaging $176.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Innocoll Pharmaceuticals Limited$10K
- W. L. Gore & Associates, Inc.$2K
- Intuitive Surgical$2K
- Davol Inc.$523
- AstraZeneca$459
- Covidien LP$360
- plus $2K from 28 others
What the payments were for
- Consulting fees$5503%
- Speaking & faculty fees$10,20059%
- Travel & lodging$1,3688%
- Food & beverage$5,17330%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Innocoll Pharmaceuticals Limited | 7 | $9,524 |
| W. L. Gore & Associates, Inc. | 15 | $2,274 |
| Intuitive Surgical | 10 | $1,714 |
| Davol Inc. | 2 | $523 |
| AstraZeneca(2 entities) | 7 | $459 |
| Covidien LP | 2 | $360 |
| Janssen Scientific Affairs, LLC | 2 | $238 |
| Optinose US, Inc. | 2 | $235 |
| AbbVie | 2 | $232 |
| Suture Ease, Inc. | 1 | $150 |
| Merck | 2 | $142 |
| Amarin Pharma, Inc. | 1 | $126 |
| Insmed, Inc. | 1 | $125 |
| Novo Nordisk | 1 | $125 |
| Medtronic | 5 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $109 |
| Shire North American Group Inc | 1 | $102 |
| Boehringer Ingelheim | 1 | $102 |
| KCI USA, Inc. | 4 | $85 |
| Seagen Inc. | 5 | $80 |
| Johnson & Johnson | 3 | $69 |
| EMD Serono, Inc. | 4 | $65 |
| Eisai Inc. | 3 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $44 |
| Boston Scientific | 2 | $43 |
| Foundation Medicine, Inc. | 2 | $31 |
| Axonics, Inc. | 1 | $27 |
| Taiho Oncology, Inc. | 2 | $25 |
| Solventum Corporation | 1 | $25 |
| Bristol Myers Squibb | 1 | $24 |
| Pfizer | 1 | $21 |
| Incyte Corporation | 1 | $16 |
| BD | 1 | $15 |
| Exelixis Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARACOLL$9,524
- Da Vinci Surgical System$1,477
- GORE SYNECOR Biomaterial$1,199
- GORE BIO-A Tissue Reinforcement$425
- GORE SYNECOR Preperitoneal Biomaterial$321
- STELARA$238
- Xhance$235
- UBRELVY$232
- GATTEX$211
- Strensiq$148
- Vascepa$126
- Arikayce$125
- DIFICID$125
- ZINPLAVA$125
- SAPHNELO$125
- Wegovy$125
- JARDIANCE$102
How this compares
$17,306 in reported general payments places this provider in the 90th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 87 | $115 |
| Oxycodone Hcl | 26 | $36 |
Paid to pharmacies, not to this prescriber.
Other surgery in Bryn Mawr
- Ronald MattsonBryn Mawr$238K
- Giorgos KarakousisPhiladelphia$8.8M
- James MarkmannPhiladelphia$1.8M
- John MiuraPhiladelphia$1.3M
- Martin WijkstromPittsburgh$1.3M
- Andy KiserPittsburgh$1.1M
- Blair JobePittsburgh$827K
- Glenn SteeleDanville$698K
- Olwadamilola FayanjuPhiladelphia$668K
- Maher El ChaarAllentown$667K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.